MENU
REGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Regeneron Pharmaceuticals (REGN) Earnings Date & Reports

Regeneron Pharmaceuticals Inc discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

REGN is expected to report earnings to fall 22.29% to $9.38 per share on April 29

Regeneron Pharmaceuticals REGN Stock Earnings Reports
Q1'25
Est.
$9.38
Q4'24
Beat
by $0.80
Q3'24
Beat
by $0.74
Q2'24
Beat
by $0.95
Q1'24
Missed
by $0.64
The last earnings report on February 04 showed earnings per share of $12.07, beating the estimate of $11.27. With 277.86K shares outstanding, the current market capitalization sits at 69.68B.
View a ticker or compare two or three
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of medicines for the treatment of serious medical conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
13450
Web
https://www.regeneron.com